HansaBioMed Life Sciences Ltd is a company entirely dedicated to research and development of products in the field of exosome sciences.
Our mission is to develop and commercialize proprietary platforms, kits, reagents and equipment for exosomes research in the Life Science market.
HansaBioMed Life Sciences offers the widest choice and selection of products dedicated to exosome research for life science applications available on the global market. As oldest and only company focused exclusively on exosome isolation and analysis, we are producing easy to use kits of highest quality. The portfolio includes lyophilized exosomes from numerous cell lines, exosome binding antibodies and kits for enrichment of specific exosome subpopulations. Moreover, HansaBioMed Life Sciences collaborates with leading international research groups, both academic and industrial, to develop further its technology platform.
Since May 2017, HansaBioMed Life Sciences is part of Lonza, a global leader in the field of biopharmaceutical development and manufacturing. As a new part of Lonza, HBM-LS will continue its product portfolio expansion of research products and support the development of cGMP-compliant exosome manufacturing processes.
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. It harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life. Further information can be found at www.lonza.com.